The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Smart Drug Delivery Systems Market Projected To Reach By 2030?
The smart drug delivery systems market size has experienced significant expansion recently. This market is projected to increase from $15.06 billion in 2025 to $18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 19.5%. Historically, this growth has been driven by factors such as the limitations of conventional drug delivery methods, the increasing prevalence of chronic diseases, advancements in biomaterials, a greater emphasis on improving patient adherence, and continuous pharmaceutical innovation.
The market for smart drug delivery systems is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $33.15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.5%. Factors contributing to this growth during the projection period include the increasing demand for personalized therapy, the wider expansion of biologics usage, greater digital health integration, regulatory support for combination devices, and advancements in nanotechnology. Key developments anticipated in the forecast period involve the integration of AI-controlled dosing, the increasing prevalence of implantable delivery systems, a growing need for targeted drug delivery, the embrace of wireless connectivity, and the proliferation of combination drug-device products.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp
What Significant Factors Are Influencing The Smart Drug Delivery Systems Market Expansion?
The smart drug delivery systems market is anticipated to expand due to the increasing incidence of chronic diseases. These conditions are long-term health issues that progress slowly over time and frequently stem from intricate causes. The growing occurrence of chronic diseases is attributed to factors such as aging populations, environmental influences, and disparities in healthcare access. Smart drug delivery systems offer a valuable method for managing chronic conditions by improving medication effectiveness and boosting patient adherence. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the rising prevalence of chronic diseases is driving the smart drug delivery systems market.
How Is The Smart Drug Delivery Systems Market Broken Down By Segment Categories?
The smart drug delivery systems market covered in this report is segmented –
1) By Product: Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-On Sensors, Other Products
2) By Therapeutic Area: Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Other Therapeutic Areas
3) By Drug Delivery Mode: Injectable, Inhalation, Oral Drug Delivery Systems
4) By End-User: Hospitals, Clinics, Home Care, Ambulatory Care Settings, Other End-Users
Subsegments:
1) By Connected Inhalers: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)
2) By Connected Autoinjectors: Single-Dose Autoinjectors, Multi-Dose Autoinjectors
3) By Connected Pen Injectors: Insulin Pen Injectors, Biologic Pen Injectors
4) By Connected Wearable Injectors: Insulin Wearable Injectors, Infusion Pump Wearable Injectors
5) By Add-On Sensors: Glucose Monitoring Sensors, Medication Adherence Sensors, Temperature Sensors
6) By Other Products: Smart Syringes, Smart Patches, Smart Implants
What Trends Are Affecting The Direction Of The Smart Drug Delivery Systems Market?
Major companies within the Smart Drug Delivery Systems market are concentrating on developing innovative solutions, such as sophisticated on-body delivery platforms, to enhance the administration of injectable therapies, improve patient convenience, and ensure precise dosing. These advanced on-body delivery platforms are wearable systems designed to deliver medication automatically and accurately over time, thereby boosting convenience, safety, and adherence to treatment. For example, in October 2024, Stevanato Group, an Italy-based pharmaceutical solutions provider, introduced its large-volume Vertiva 10 mL on-body delivery system platform at CPHI Milan. This platform is engineered to support high-volume injectable therapies, offering improved usability, safety, and treatment adherence, thus addressing the rising demand for patient-centric drug delivery solutions.
Which Players Are Present In The Smart Drug Delivery Systems Market Space?
Major companies operating in the smart drug delivery systems market are Johnson & Johnson, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Novo Nordisk, Becton Dickinson and Company, Baxter International Inc, Phillips-Medisize Corporation, ResMed Inc, West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation, Ypsomed Holding AG, Nemera, Gerresheimer AG, Haselmeier AG, SHL Medical, Aptar Pharma
Get The Full Smart Drug Delivery Systems Market Report:
https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report
Which Geographic Region Dominates The Smart Drug Delivery Systems Market?
North America was the largest region in the smart drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Smart Drug Delivery Systems Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report
Browse Through More Reports Similar to the Global Smart Drug Delivery Systems Market 2026, By The Business Research Company
Electronic Drug Delivery Systems Market Report 2026
Advanced Drug Delivery Systems Market Report
Pharmaceutical Drug Delivery Market Report
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model